Results 221 to 230 of about 283,736 (263)

Adiponectin in chronic hepatitis C

Clinical Journal of Gastroenterology, 2013
White adipose tissue has been increasingly recognized as an important endocrine organ that secretes a number of biologically active adipokines. Adiponectin, one of the major adipokines, possesses anti-inflammatory and insulin-sensitizing properties, and its serum levels typically decline with increasing body weight.
Toru, Arano, Hayato, Nakagawa, Hitoshi, Ikeda, Kazuhiko, Koike   +3 more
openaire   +2 more sources

Update on Chronic Hepatitis C

Clinical Gastroenterology and Hepatology, 2005
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Winnie, Wong, Norah, Terrault
openaire   +2 more sources

Pathology of Chronic Hepatitis B and Chronic Hepatitis C

Clinics in Liver Disease, 2010
Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire   +2 more sources

Chronic Hepatitis C in Pregnancy

Obstetrics & Gynecology, 2008
To estimate outcomes, to determine whether appropriate follow-up was performed for pregnant patients with hepatitis C virus (HCV), and to show that maternal and neonatal complications would be higher in the HCV-positive group.We compared pregnant women from a drug dependence and treatment program who were HCV antibody-positive with those who were HCV ...
Eliza M F, Berkley, Kimberly K, Leslie, Sanjeev, Arora, Clifford, Qualls, Jeffrey C, Dunkelberg   +4 more
openaire   +2 more sources

THERAPY FOR CHRONIC HEPATITIS C

Gastroenterology Clinics of North America, 1994
Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients.
G L, Davis, J Y, Lau, H L, Lim
openaire   +2 more sources

Therapy for chronic hepatitis C

Journal of Physiology-Paris, 2001
in Hungary, over the past 5 years more than 900 patients with chronic hepatitis C have been examined for treatment with interferon at 16 major hepatology centres, using unified diagnostic and therapeutical criteria. Authors give an account of their experiences on the clinical features of patients with chronic hepatitis C and report the results of the ...
Pár, Alajos, Telegdy, László, Dalmi, Lajos, Müller, Éva   +3 more
openaire   +3 more sources

Treatment of chronic hepatitis C

Journal of Hepatology, 1991
alpha-Interferon given subcutaneously at doses between 1-3 million units leads to responses in about 50% of patients suffering from chronic hepatitis C. A 24-week treatment is frequently (approx. 50%) followed by relapses reducing the percentage of lasting responders to approx. 20%.
openaire   +2 more sources

Hepatitis C virus genotypes in chronic hepatitis C of children

Journal of Viral Hepatitis, 1996
SUMMARY.Several hepatitis C virus (HCV) genotypes have been recently identified and genotype 1b has been correlated with severe liver disease and a poor response to interferon therapy. HCV infection in children is an interesting model for evaluation of the relationship between HCV genotypes and liver disease, because of its relatively short duration ...
BORTOLOTTI, FLAVIA, VAJRO P, BALLI F, GIACCHINO R, CRIVELLARO C, BARBERA C, PONTISSO, PATRIZIA, NEBBIA C, ZANCAN, LUCIA, BERTOLINI A, ALBERTI, ALFREDO   +10 more
openaire   +4 more sources

Treatment for chronic hepatitis C

Current Gastroenterology Reports, 2003
Approximately four million Americans have been exposed to the hepatitis C virus (HCV) and are anti-HCV positive; almost three million are chronically infected and HCV RNA positive. Treatment for chronic hepatitis C has improved rapidly over the past 12 years from interferon monotherapy, with a sustained virologic response (SVR) rate of about 10% in the
openaire   +2 more sources

Hepatic sarcoidosis associated with chronic hepatitis C

Journal of Gastroenterology, 2002
A 57-year-old woman with sarcoidosis was referred because of the appearance of multiple small low-attenuation areas in the liver on computed tomography (CT). A liver biopsy specimen showed chronic active hepatitis accompanied by sarcoid granulomas. The patient received prednisolone and, later, interferon-alpha.
Shinwa, Yamada, Shinichiro, Mine, Takeshi, Fujisaki, Norihiro, Ohnari, Sumiya, Eto, Yoshiya, Tanaka   +5 more
openaire   +2 more sources